First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer.

Chiara MercinelliMarco MoschiniAntonio CigliolaBenedetta MattorreValentina Tateo Giuseppe Basile Laura L Cogrossi Brigida Anna MaioranoDamiano A PatanèDaniele Raggi Giovanni L Pastorino Chiara Re Maurizio Colecchia Roberta LucianòRenzo ColomboGiorgio BrembillaFrancesco De CobelliAlberto BrigantiDean C Pavlick Jeffery S RossFrancesco MontorsiMaria Teresa Sabrina Bertilaccio Andrea Necchi

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)

To our knowledge, the first results from NURE-Combo trial suggest that this combination could expand the therapeutic opportunities of immune-chemotherapy in patients with MIBC.

Keyphrases

phase ii study
locally advanced
muscle invasive bladder cancer
rectal cancer
squamous cell carcinoma
radiation therapy
open label
phase iii
healthcare
early stage
phase ii
study protocol
clinical trial
advanced non small cell lung cancer
lymph node
randomized controlled trial
placebo controlled
double blind